PNT News and Press, POINT Biopharma Global Inc. From 10/03/23

2023-10-03 18:33:22 ET Eli Lilly 's (NYSE: LLY) latest acquisition didn't exactly meet with widespread shareholder approval on Tuesday. After announcing that it signed a deal to acquire Point Biopharma Global (NASDAQ: PNT) , its share price headed south to end the day 2.4% l...

2023-10-03 13:52:18 ET Shares of Point Biopharma Global (NASDAQ: PNT) were up by more than 85% as of 11:45 a.m. ET on Tuesday after the healthcare company entered into a buyout agreement. The stock is up more than 70% this year. Point Biopharma is a clinical-stage company th...

2023-10-03 13:32:22 ET Summary Eli Lilly's acquisition of POINT Biopharma Global strategically boosts its portfolio in radiopharmaceuticals, with immediate late-stage clinical assets and manufacturing capabilities. POINT Biopharma's financial health is stable with a 27-month cash ...

2023-10-03 12:12:51 ET DENVER, Colo., Oct 3, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; ALX Oncology Holdings (NASDAQ: ALXO), POINT Biopharma Global (NASDAQ: PNT), SciSparc (NASD...

2023-10-03 10:29:23 ET Shares of Point Biopharma Global Inc (NASDAQ: PNT) close to doubled this morning after Eli Lilly & Co (NYSE: LLY) announced plans of acquiring the cancer treatment company. Details of Lilly-Point agreement Lilly is willing to pay about $1.4 billion for...

2023-10-03 09:59:26 ET DENVER, Colo., Oct 3, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; ALX Oncology Holdings (NASDAQ: ALXO), POINT Biopharma Global (NASDAQ: PNT), SciSparc (NASDAQ: SPRC), ODDITY Tec...

2023-10-03 08:37:00 ET U.S. stock index futures on Tuesday pointed to a lower open, as longer-end Treasury yields surged amid a bruising bond sell-off. Market participants will also be receiving data on the labor market in the form of the Job Openings and Labor Turnover Survey (JOLTS). ...

2023-10-03 07:17:09 ET More on POINT Biopharma POINT Biopharma: Leading The Future Of Radioligand Therapy POINT Biopharma: Stock Has Upcoming Catalysts With 2 Therapies In Phase 3 Trials POINT Biopharma slips after pipeline update Seeking Alpha’s Quant...

Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies PR Newswire INDIANAPOLIS , Oct. 3, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and POINT Biopharma Global, Inc. (NASDAQ: PNT) today an...

INDIANAPOLIS and SCHLIEREN-ZURICH, Switzerland, Sept. 18, 2023 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, and Athe...